Approximately 20 g of protein was loaded onto a Bolt 412% Bis-Tris Plus Gel (Invitrogen) and run at 180 V for 45 min
We included only comparative studies
TB-500 separate (typically 4-8x 5mg vials for 4-week protocol)
As a research tool, BPC-157 does not correspond to any known endogenous receptor ligand but has demonstrated interactions with several signaling systems in preclinical models
On one hand, ACSL4 amplifies lipogenic transcriptional programs, enhances fatty acid oxidationmediated energy adaptation, and cooperates with oncogenic signaling networks to promote tumor proliferation and survival, particularly under nutrient stress such as transarterial chemoembolization (TACE)
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, et al